GlycoMimetics Inc | TalkMarkets

Latest Posts

Week In Review: OrbiMed Raises $800 Million For Its Fourth Asia Fund

Article By: ChinaBio® Today

Saturday, March 6, 2021 12:34 PM EDT

OrbiMed Advisors announced it has secured $3.5 billion in commitments for its latest capital raise, including $800 million for OrbiMed Asia Partners IV. Connect Biopharma of Taicang has filed for a NASDAQ IPO that could raise $100 million.

In this article: AZN, SCLN, GLYC

Read

Week In Review: Zai Lab Completes Second Listing With $761 Million HK IPO

Article By: ChinaBio® Today

Saturday, October 3, 2020 2:17 PM EDT

Zai Lab raised $761 million in a Hong Kong IPO and rose 8.5% in its first trading session to a market cap of $6.8 billion. XtalPi closed a $318.8 million oversubscribed Series C funding co-led by SoftBank Vision Fund2, PICC Capital, and Morningside

In this article: PFE, GLYC, BHVN, ZLAB

Read

Morning Call For Tuesday, March 20

Article By: Jim Van Meerten

Tuesday, March 20, 2018 9:16 AM EDT

Jun E-mini S&Ps (ESM18 +0.15%) this morning are up +0.06% as a +1.03% rally in May WTI crude oil (CLK18 +1.30%) lifts energy stocks.

In this article: GPI, PTI, SIG, TKR, ARNA, ELGX, ADBE, ORCL, RCII, MRNS, GLYC, HQY, BB

Read

Morning Call For Tuesday, March 6

Article By: Jim Van Meerten

Tuesday, March 6, 2018 8:50 AM EDT

Mar E-mini S&Ps (ESH18 +0.43%) this morning are up +0.46% and European stocks are up +0.92% on signs the U.S. may not go through with plans to put tariffs on metal imports.